Table 1.
Base line characteristics |
CAD patients
(n=103) |
Controls
(n=102) |
P-value |
---|---|---|---|
Age (years) | 59.08±8.78 | 61.14±11.07 | 0.14 |
Male (%) | 43(49.4%) | 44(50.6 %) | 0.50 |
Height (cm) | 161.02±9.81 | 161.39±8.73 | 0.777 |
Weight (kg) | 70.03±13.94 | 69.77±12.77 | 0.893 |
BMI (kg/m²) | 26.97±4.82 | 26.33±4.61 | 0.333 |
Obesity (%) | 28.2% | 12.6% | 0.006 |
SBP (mm Hg) | 137.25±26.58 | 122.27±18.83 | 0.000 |
DBP (mm Hg) | 83.77±12.83 | 73.20±13.05 | 0.000 |
Hypertension a (%) | 54.36% | 32% | 0.005 |
TC (mg/dl) | 171.19±32.24 | 192.72±27.37 | 0.000 |
TG (mg/dl) | 152.57±67.55 | 181.10±53.73 | 0.001 |
FBS (mg/dl) | 140.35±64.49 | 122.19±39.62 | 0.016 |
HDL (mg/dl) | 38.94±7.47 | 41.80±5.83 | 0.002 |
LDL (mg/dl) | 101.02±23.49 | 115.1±23.26 | 0.000 |
Smokingb (%) | 43.7% | 7.8% | 0.000 |
Diabetes c | 49% | 33% | 0.012 |
Data presented as mean±SD, n (%) of cases or median.
Systolic blood pressure above 140 mmHg, and/or diastolic blood pressure above 90 mmHg, and/or history of hypertension, and/or current anti-hypertensive medication.
Ceased smoking >1 year prior to enrolment and
diabetes (fasting blood sugar above 126 mg/dL) BMI: body mass index; SBP: systolic blood pressure; DBP: diastolic blood pressure; TC: total cholesterol; TG: triglycerides; FBS: fasting blood sugar; HDL: high-density lipoprotein cholesterol; LDL: low-density lipoprotein cholesterol.